Trending Now

Member Spotlight: Jon Burlinson

As the Co-Founder and CEO of DealBridge.ai, Jon Burlinson has over 25 years of experience in information management, software engineering, and technical management. He is passionate about delivering advanced SaaS solutions that leverage AI and data analytics to automate tasks, optimize decision-making, and provide valuable insights, ultimately enhancing efficiency and driving better deal outcomes.

Company Name & Description: DealBridge.ai is the first Deal Relationship Management (DRM) platform, revolutionizing the way private market deals are handled. Harnessing the power of Generative AI and other advanced algorithms, DealBridge.ai automates the complexities and non-linearity of deal-making.

The platform streamlines origination, due diligence, and distribution of private assets, eliminating traditional, labor-intensive processes. DealBridge.ai empowers sellers and buyers of alternative products to connect effortlessly at the deal level, enhancing the overall human experience and allowing users to focus on building and nurturing valuable relationships. With automation at its core, DealBridge.ai maximizes revenue potential and elevates deal-making capabilities in private markets.

Company Website: https://DealBridge.ai

Year Founded: 2021

Headquarters: New York

Area of Focus: Building solutions for the litigation finance community. He aims to solve core issues that have plagued the space for years, facilitating more efficient and effective deal management for all stakeholders.

Member Quote: “Litigation finance evens the odds, granting access to legal recourse for parties who might otherwise be outmatched. Advanced technologies such as AI and blockchain are becoming game-changers in the litigation finance sector. They are instrumental in transforming the way we handle legal transactions, making them more transparent, streamlined, and accessible to all stakeholders involved.”

Commercial

View All

Omni Bridgeway Backs Australian Class Action Targeting Johnson & Johnson

By Harry Moran |

A class action was recently filed in the Federal Court of Australia, targeting Johnson & Johnson over allegations that a number of its oral cold and flu medications are ineffective when taken orally. The claim covers 20 separate products sold by Johnson & Johnson across three brands of medication: Codral, Sudafed, and Benadryl.

An article in Lawyers Weekly covers the class action being brought by JGA Saddler, with funding for the case provided by Omni Bridgeway. The pharmaceutical giant is accused of falsely marketing and selling these products as effective treatments, with the claim seeking to represent any Australian customer who has bought one of these products since 2005.

Rebecca Jancauskas, director at JGA Saddler, stated that “Johnson & Johnson has manufactured and marketed a medication that decades of evidence have shown doesn’t work as claimed.” She also emphasised the importance of the claim in seeking compensation by saying, “customers should be able to confidently buy medicines that work as advertised and when they don’t, the company involved should be held accountable.”

Niall Watson-Dunne, investment manager at Omni Bridgeway, said that “for around 19 years, Australians have been sold cold and flu products to relieve their symptoms, despite studies and scientific evidence showing their key ingredient phenylephrine is ineffective when taken orally.”

More information about the class action can be found on Omni Bridgeway’s website.

Qanlex Refines its Latin America Strategy

By Harry Moran |

Qanlex is one of the few litigation funders focused on providing third-party financing in Latin America, with a dedicated presence in the region. The funder leverages a sector-specific strategy for targeting lucrative case types.

Speaking with América Economía, Qanlex’s general counsel for Latin America, Juliana Giorgi, emphasised that in order to gain a foothold in the competitive litigation funding market, the firm has leveraged “the development of technology.” Giorgi goes on to explain that its in-house software “searches for cases in judicial databases that might interest us due to the value of the claim or the nature of the process”, allowing Qanlex to find suitable claims to finance in the different countries it operates in.

Beyond the use of technology to refine its strategies, Qanlex has also chosen to focus on specific sectors that generate valuable disputes in Latin America. Whilst the construction sector has been a particular area of interest, Qanlex has also found opportunities for niche areas within different jurisdictions. As Giorgi explains: “In Ecuador we have several energy cases that include thermoelectric plants; in Costa Rica, cases of tourist real estate development; in Colombia, oil and energy cases."

Regardless of the sector, Gorgi acknowledges that Qanlex is “open to analyzing and financing any range of cases as long as they include a liquid asset transfer at the end of which the fund can take the remuneration.”

Emmerson PLC Obtains $11M in Funding for Moroccan Dispute

By John Freund |

Emmerson PLC, the mining company focused on the development of the Khemisset potash project in Morocco, has secured $11 million in legal funding for its dispute against the Moroccan government.

As reported in Business Insider, Emmerson obtained the funding from an unnamed legal funder. The proceeds will be used to commence with arbitration proceedings, with white shoe law firm Boies Schiller Flexner LLP being appointed litigation counsel.

LFJ recently reported on Emmerson's search for litigation funding, including that it is pursuing an investment dispute over the government’s alleged breaches of a bilateral investment treaty (BIT) between Morocco and the United Kingdom. Emmerson is seeking to establish itself as a low-cost, high-margin supplier of potash on the African continent.

We will keep you updated as this story progresses.